Explore more publications!
Trinidad & Tobago Business News
Submit Press Release

Trinidad & Tobago Business News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Trinidad & Tobago Business News.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 8, 2025

FCX Investor News: If You Have Suffered Losses in Freeport-McMoRan Inc. (NYSE: FCX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
November 8, 2025

FCX Investor News: If You Have Suffered Losses in Freeport-McMoRan Inc. (NYSE: FCX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Indeterminate GlobeNewswire
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages WPP plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - WPP
November 8, 2025

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages WPP plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - WPP

Indeterminate GlobeNewswire
Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
November 8, 2025

Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

Indeterminate GlobeNewswire
CRMT Investor News: If You Have Suffered Losses in America’s Car-Mart, Inc. (NASDAQ: CRMT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
November 8, 2025

CRMT Investor News: If You Have Suffered Losses in America’s Car-Mart, Inc. (NASDAQ: CRMT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Indeterminate GlobeNewswire
Stan Taylor Launches The Black Book of Power, Calling for a Consciousness Shift as 60,000 Readers Embrace Counter-Manipulation Training
November 8, 2025

Stan Taylor Launches The Black Book of Power, Calling for a Consciousness Shift as 60,000 Readers Embrace Counter-Manipulation Training

Indeterminate GlobeNewswire
Inspire Medical Systems, Inc. (INSP) Faces Investor Suit Over Disastrous Inspire V Launch-- Hagens Berman
November 8, 2025

Inspire Medical Systems, Inc. (INSP) Faces Investor Suit Over Disastrous Inspire V Launch-- Hagens Berman

Indeterminate GlobeNewswire
ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATYR
November 8, 2025

ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATYR

Indeterminate GlobeNewswire
MOH FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Molina Healthcare, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MOH
November 8, 2025

MOH FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Molina Healthcare, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MOH

Indeterminate GlobeNewswire
Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions 2025
November 8, 2025

Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions 2025

Indeterminate GlobeNewswire
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
November 8, 2025

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Indeterminate GlobeNewswire
RZoasis Announces the Launch of RZUSD, a Transparent Stablecoin Amid Growing Shift Away from Centralized Alternatives
November 8, 2025

RZoasis Announces the Launch of RZUSD, a Transparent Stablecoin Amid Growing Shift Away from Centralized Alternatives

Indeterminate GlobeNewswire
FLR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Fluor Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – FLR
November 8, 2025

FLR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Fluor Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – FLR

Indeterminate GlobeNewswire
AI Meets Digital Assets: CreditBlockchain Launches Free Cloud Trial for XRP Investors Era
November 8, 2025

AI Meets Digital Assets: CreditBlockchain Launches Free Cloud Trial for XRP Investors Era

Indeterminate GlobeNewswire
ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Avantor, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AVTR
November 8, 2025

ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Avantor, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AVTR

Indeterminate GlobeNewswire
Monte Rosa Therapeutics Presents Preclinical Data at AHA Scientific Sessions 2025 on the Potential of MRT-8102, a NEK7-directed Molecular Glue Degrader, to Treat Cardiovascular and Cardiometabolic Diseases
November 8, 2025

Monte Rosa Therapeutics Presents Preclinical Data at AHA Scientific Sessions 2025 on the Potential of MRT-8102, a NEK7-directed Molecular Glue Degrader, to Treat Cardiovascular and Cardiometabolic Diseases

Indeterminate GlobeNewswire
Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK™-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy
November 8, 2025

Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK™-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy

Indeterminate GlobeNewswire
IGEL läutet neue Ära der EUC-Transformation und vertrauenswürdigen Endpunktsicherheit ein
November 8, 2025

IGEL läutet neue Ära der EUC-Transformation und vertrauenswürdigen Endpunktsicherheit ein

Indeterminate GlobeNewswire
PALOMAR HEALTH MEDICAL GROUP ALERT: Bragar Eagel & Squire, P.C. is Investigating the Palomar Health Medical Group Data Breach
November 8, 2025

PALOMAR HEALTH MEDICAL GROUP ALERT: Bragar Eagel & Squire, P.C. is Investigating the Palomar Health Medical Group Data Breach

Indeterminate GlobeNewswire
Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrology Kidney Week 2025
November 8, 2025

Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrology Kidney Week 2025

Indeterminate GlobeNewswire
AGL Investor News: If You Have Suffered Losses in agilon health, inc. (NYSE: AGL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
November 8, 2025

AGL Investor News: If You Have Suffered Losses in agilon health, inc. (NYSE: AGL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions